Short-term impact of sucralose consumption on the metabolic response and gut microbiome of healthy adults

British Journal of Nutrition

Volumn 122, Issue 8, 2019, Pages 856-862

  Thomson, Pamela ^a   Santibañez, Rodrigo ^a   Aguirre, Carolina ^b   Galgani, Jose E ^b   Garrido, Daniel ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Glucose control; Gut microbiome; Insulin; Non energy artificial sweeteners; Sucralose

Indexed keywords

GLUCOSE; INSULIN; PLACEBO; SUCRALOSE; RNA 16S; SUCROSE; SWEETENING AGENT; TRICHLOROSUCROSE;

ACTINOBACTERIA; ADULT; ARTICLE; BACTEROIDETES; BODY WEIGHT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOCRINE FUNCTION TEST; FIRMICUTES; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULINEMIA; INTESTINE FLORA; MALE; MATSUDA INDEX; NORMAL HUMAN; OBESITY; POPULATION ABUNDANCE; PROTEOBACTERIA; RANDOMIZED CONTROLLED TRIAL; RNA SEQUENCE; SPECIES COMPOSITION; VERRUCOMICROBIA; ADOLESCENT; CALORIC INTAKE; DRUG EFFECT; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; DOUBLE-BLIND METHOD; ENERGY INTAKE; GASTROINTESTINAL MICROBIOME; HEALTHY VOLUNTEERS; HUMANS; INSULIN RESISTANCE; MALE; RNA, RIBOSOMAL, 16S; SUCROSE; SWEETENING AGENTS; YOUNG ADULT;

EID: 85068382358     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114519001570     Document Type: Article

References (40)

1. Magnuson BA, Carakostas MC, Moore NH, et al. (2016) Biological fate of low-calorie sweeteners. Nutr Rev 74, 670-689.
2. Martyn D, Darch M, Roberts A, et al. (2018) Low-/no-calorie sweeteners: a review of global intakes. Nutrients 10, 357.
3. Shearer J & Swithers SE (2016) Artificial sweeteners and metabolic dysregulation: lessons learned from agriculture and the laboratory. Rev Endocr Metab Disord 17, 179-186.
4. Suez J, Korem T, Zeevi D, et al. (2014) Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514, 181-186.
5. Omran A, Ahearn G, Bowers D, et al. (2013) Metabolic effects of sucralose on environmental bacteria. J Toxicol 2013, 372986.
6. Wang Q-P, Browman D, Herzog H, et al. (2018) Non-nutritive sweeteners possess a bacteriostatic effect and alter gut microbiota in mice. PLOS ONE 13, e0199080.
7. Sylvetsky AC, Bauman V, Blau JE, et al. (2017) Plasma concentrations of sucralose in children and adults. Toxicol Environ Chem 99, 535-542.
8. RobertsA, RenwickAG, Sims J, et al. (2000) Sucralosemetabolism and pharmacokinetics in man. Food Chem Toxicol 38, 31-41.
9. Rodriguez-Palacios A, Harding A, Menghini P, et al. (2018) The artificial sweetener Splenda promotes gut proteobacteria, dysbiosis, and myeloperoxidase reactivity in Crohn's disease-like ileitis. Inflamm Bowel Dis 24, 1005-1020.
10. Grotz VL, Pi-Sunyer X, Porte D, et al. (2017) A 12-week randomized clinical trial investigating the potential for sucralose to affect glucose homeostasis. Regul Toxicol Pharmacol 88, 22-33.
11. Grotz VL, Henry RR, McGill JB, et al. (2003) Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. J Am Diet Assoc 103, 1607-16121711.
12. Lobach AR, Roberts A & Rowland IR (2019 Assessing the in vivo data on low/no-calorie sweeteners and the gut microbiota. Food Chem Toxicol 124, 385-399.
13. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
14. Matsuda M & DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470.
15. Krzyzanski W & Jusko WJ (1998) Integrated functions for four basic models of indirect pharmacodynamic response. J Pharm Sci 87, 67-72.
16. Galgani JE, Vasquez K, Watkins G, et al. (2013) Enhanced skeletal muscle lipid oxidative efficiency in insulin-resistant vs insulin-sensitive nondiabetic, nonobese humans. J Clin Endocrinol Metab 98, E646-E653.
17. Medina DA, Pedreros JP, Turiel D, et al. (2017) Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients. PeerJ 2017, e3443.
18. Comeau AM, Douglas GM & Langille MGI (2017) Microbiome helper: a custom and streamlined workflow for microbiome research. mSystems 2, e00127-16.
19. Callahan BJ, McMurdie PJ, Rosen MJ, et al. (2016) DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 13, 581-583.
20. Callahan BJ, McMurdie PJ & Holmes SP (2017) Exact sequence variants should replace operational taxonomic units in markergene data analysis. ISME J 11, 2639-2643.
21. Wang Q, Garrity GM, Tiedje JM, et al. (2007) Na?ve Bayesian classifier for rapid assignment of rRNA sequences. Appl Environ Microbiol 73, 5261-5267.
22. Quast C, Pruesse E, Yilmaz P, et al. (2013) The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41, D590-D596.
23. Schweer T, Parfrey LW, Quast C, et al. (2013) The SILVA and 'All-species Living Tree Project (LTP)' taxonomic frameworks. Nucleic Acids Res 42, D643-D648.
24. Lozupone CA, Hamady M, Kelley ST, et al. (2007) Quantitative and qualitative ? diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol 73, 1576-1585.
25. Lozupone C, Lladser ME, Knights D, et al. (2011) UniFrac: an effective distance metric for microbial community comparison. ISME J. 5, 169-172.
26. Schiffman SS & Rother KI (2013) Sucralose, a synthetic organochlorine sweetener: overview of biological issues. J Toxicol Environ Heal B Crit Rev 16, 399-451.
27. Swithers SE (2013) Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends Endocrinol Metab 24, 431-441.
28. Johannsen FR & Levinskas GJ (1987) Acute and subchronic toxicity of tetramethylcyclohexanes. J Appl Toxicol 7, 245-248.
29. Grice HC & Goldsmith LA (2000) Sucralose-an overview of the toxicity data. Food Chem Toxicol 38, 1-6.
30. Magnuson BA, Roberts A & Nestmann ER (2017) Critical review of the current literature on the safety of sucralose. Food Chem. Toxicol 106, 324-355.
31. Suez J, Korem T, Zilberman-Schapira G, et al. (2015) Noncaloric artificial sweeteners and the microbiome: findings and challenges. Gut Microbes 6, 149-155.
32. Omran A, Baker R & Coughlin C (2013) Differential bacteriostatic effects of sucralose on various species of environmental bacteria. ISRN Toxicol 2013, 415070.
33. Bian X, Chi L, Gao B, et al. (2017) Gut microbiome response to sucralose and its potential role in inducing liver inflammation in mice. Front Physiol 8, 487.
34. Zhao S, Liu W, Wang J, et al. (2017) Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice. J Mol Endocrinol 58, 1-14.
35. Everard A, Belzer C, Geurts L, et al. (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110, 9066-9071.
36. Most J, Goossens GH, Reijnders D, et al. (2017) Gut microbiota composition strongly correlates to peripheral insulin sensitivity in obese men but not in women. Benef Microbes 8, 557-562.
37. Sircana A, Framarin L, Leone N, et al. (2018) Altered gut microbiota in type 2 diabetes: just a coincidence? Curr Diab Rep 18, 98.
38. Kasai C, Sugimoto K, Moritani I, et al. (2015) Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol 15, 100.
39. Ley RE, Mardis ER, Magrini V, et al. (2006) An obesityassociated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
40. Boulange CL, Neves AL, Chilloux J, et al. (2016) Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med 8, 42.